We are live on ! Find out more
RBC

Roble Belko & Company Portfolio holdings

AUM $925M
1-Year Est. Return 19.7%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+19.7%
3 Year Est. Return
+53.27%
5 Year Est. Return
+47.85%
10 Year Est. Return
+149.75%
AUM
$504M
AUM Growth
+$14.7M
Cap. Flow
-$5.5M
Cap. Flow %
-1.09%
Top 10 Hldgs %
55.23%
Holding
341
New
21
Increased
27
Reduced
60
Closed
20
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AJG icon
76
Arthur J. Gallagher & Co
AJG
$64.3B
$255K 0.05%
1,162
PG icon
77
Procter & Gamble
PG
$342B
$249K 0.05%
1,643
IBDR icon
78
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.39B
$237K 0.05%
10,105
IBDS icon
79
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.84B
$230K 0.05%
9,779
IVW icon
80
iShares S&P 500 Growth ETF
IVW
$77.1B
$225K 0.04%
3,196
QCOM icon
81
Qualcomm
QCOM
$165B
$220K 0.04%
1,847
ENB icon
82
Enbridge
ENB
$113B
$219K 0.04%
5,890
JPM icon
83
JPMorgan Chase
JPM
$955B
$219K 0.04%
1,504
PFE icon
84
Pfizer
PFE
$147B
$214K 0.04%
5,829
-5,993
-51% -$233K
OI icon
85
O-I Glass
OI
$1.15B
$213K 0.04%
+10,000
New +$216K
SPDW icon
86
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$41.3B
$208K 0.04%
6,392
IBDV icon
87
iShares iBonds Dec 2030 Term Corporate ETF
IBDV
$3.28B
$206K 0.04%
+9,707
New +$207K
IYW icon
88
iShares US Technology ETF
IYW
$24.9B
$200K 0.04%
1,835
CSCO icon
89
Cisco
CSCO
$479B
$192K 0.04%
3,716
-418
-10% -$20.6K
CVS icon
90
CVS Health
CVS
$126B
$187K 0.04%
2,700
C icon
91
Citigroup
C
$231B
$184K 0.04%
4,000
ADP icon
92
Automatic Data Processing
ADP
$107B
$180K 0.04%
821
DFAC icon
93
Dimensional US Core Equity 2 ETF
DFAC
$49.2B
$176K 0.03%
6,477
CTVA icon
94
Corteva
CTVA
$52.5B
$172K 0.03%
3,000
DFIV icon
95
Dimensional International Value ETF
DFIV
$21.5B
$170K 0.03%
5,184
NOW icon
96
ServiceNow
NOW
$121B
$168K 0.03%
1,495
IJT icon
97
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.45B
$163K 0.03%
1,420
IWM icon
98
iShares Russell 2000 ETF
IWM
$82.5B
$156K 0.03%
835
GLW icon
99
Corning
GLW
$135B
$154K 0.03%
4,400
LULU icon
100
lululemon athletica
LULU
$14B
$154K 0.03%
407

Similar funds

Roble Belko & Company's Q2 2023 Portfolio in Review

As of Q2 2023, Roble Belko & Company held 341 positions worth $504M, up 3% from $489M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Roble Belko & Company's Q2 2023 filing shows 21 new, 27 increased, 60 reduced and 20 closed positions. Its largest new stake was O-I Glass: 10,000 shares worth $213K. The largest sale was Vanguard International Dividend Appreciation ETF, an estimated $14.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 1.9% of assets, up from 1.9% a quarter earlier, followed by Real Estate and Technology.

  • Roble Belko & Company's largest Q2 2023 buy was O-I Glass: 10,000 shares worth $213K.
  • Roble Belko & Company added most to Vanguard International High Dividend Yield ETF in Q2 2023, an estimated $12.9M increase.
  • Roble Belko & Company's biggest Q2 2023 reduction was Vanguard International Dividend Appreciation ETF, cutting an estimated $14.3M.
  • Roble Belko & Company fully exited iShares MSCI All Country Asia ex Japan ETF in Q2 2023, selling an estimated $1.11M.
  • Roble Belko & Company's ten largest holdings make up 55% of its $504M portfolio in Q2 2023.
  • Roble Belko & Company opened 21 new positions and closed 20 in Q2 2023.
  • Roble Belko & Company's portfolio value rose 3% quarter-over-quarter to $504M.

Based on Roble Belko & Company's 13F filing for Q2 2023, filed 4 Aug 2023.